p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells

Liver Cancer 0301 basic medicine Carcinoma, Hepatocellular Cell Survival NF-E2-Related Factor 2 Oncology and Carcinogenesis Chronic Liver Disease and Cirrhosis Mice, Transgenic Mechanistic Target of Rapamycin Complex 1 Transgenic Proto-Oncogene Proteins c-myc Experimental Mice 03 medical and health sciences Rare Diseases Neoplasms Sequestosome-1 Protein Animals Humans Diethylnitrosamine Oncology & Carcinogenesis Cancer Neoplastic Biomedical and Clinical Sciences Liver Disease TOR Serine-Threonine Kinases Carcinoma Liver Neoplasms Neurosciences Hepatocellular Oncology and carcinogenesis Neoplasms, Experimental Up-Regulation Gene Expression Regulation, Neoplastic Gene Expression Regulation Biochemistry and cell biology Multiprotein Complexes Neoplastic Stem Cells Digestive Diseases
DOI: 10.1016/j.ccell.2016.04.006 Publication Date: 2016-05-21T04:27:31Z
ABSTRACT
p62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs). Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored. Here we show that p62 is necessary and sufficient for HCC induction in mice and that its high expression in non-tumor human liver predicts rapid HCC recurrence after curative ablation. High p62 expression is needed for activation of NRF2 and mTORC1, induction of c-Myc, and protection of HCC-initiating cells from oxidative stress-induced death.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (67)
CITATIONS (391)